FONAR (FONR) Competitors $13.76 +0.22 (+1.59%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. CVRX, SNWV, TCMD, ZIMV, SMTI, LUNG, RCEL, NVRO, ELMD, and PROFShould you be buying FONAR stock or one of its competitors? The main competitors of FONAR include CVRx (CVRX), SANUWAVE Health (SNWV), Tactile Systems Technology (TCMD), ZimVie (ZIMV), Sanara MedTech (SMTI), Pulmonx (LUNG), AVITA Medical (RCEL), Nevro (NVRO), Electromed (ELMD), and Profound Medical (PROF). These companies are all part of the "medical equipment" industry. FONAR vs. CVRx SANUWAVE Health Tactile Systems Technology ZimVie Sanara MedTech Pulmonx AVITA Medical Nevro Electromed Profound Medical CVRx (NASDAQ:CVRX) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability, community ranking and risk. Does the media favor CVRX or FONR? In the previous week, CVRx and CVRx both had 1 articles in the media. CVRx's average media sentiment score of 1.79 beat FONAR's score of 0.97 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive FONAR 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, CVRX or FONR? CVRx has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Do institutionals and insiders hold more shares of CVRX or FONR? 75.3% of CVRx shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 18.9% of CVRx shares are held by insiders. Comparatively, 2.2% of FONAR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor CVRX or FONR? FONAR received 147 more outperform votes than CVRx when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 73.33% of users gave CVRx an outperform vote. CompanyUnderperformOutperformCVRxOutperform Votes3373.33% Underperform Votes1226.67% FONAROutperform Votes18074.69% Underperform Votes6125.31% Which has stronger valuation & earnings, CVRX or FONR? FONAR has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M6.27-$59.97M-$2.69-4.59FONAR$101.57M0.85$10.57M$1.1512.13 Is CVRX or FONR more profitable? FONAR has a net margin of 7.68% compared to CVRx's net margin of -116.91%. FONAR's return on equity of 4.94% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-116.91% -93.06% -51.78% FONAR 7.68%4.94%3.70% Do analysts recommend CVRX or FONR? CVRx presently has a consensus price target of $17.83, suggesting a potential upside of 44.28%. Given CVRx's stronger consensus rating and higher possible upside, equities research analysts plainly believe CVRx is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryFONAR beats CVRx on 9 of the 17 factors compared between the two stocks. Remove Ads Get FONAR News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFONARElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.53M$3.27B$5.58B$7.58BDividend YieldN/A1.64%5.35%4.04%P/E Ratio12.1314.8922.9318.20Price / Sales0.8542.38363.8086.45Price / Cash4.7844.0938.1634.64Price / Book0.543.296.534.03Net Income$10.57M$94.03M$3.21B$247.18M7 Day Performance-1.34%-3.82%-5.78%-5.56%1 Month Performance-4.26%-11.68%-0.08%-6.69%1 Year Performance-29.22%-23.02%6.48%-3.47% FONAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFONAR1.4271 of 5 stars$13.80+1.9%N/A-32.5%$85.60M$101.57M12.00480Positive NewsCVRXCVRx2.1871 of 5 stars$12.76+2.2%$17.83+39.8%-24.5%$332.22M$51.29M-4.74160News CoveragePositive NewsGap DownSNWVSANUWAVE HealthN/A$38.71+2.9%N/AN/A$330.93M$29.30M-9.9340Gap DownHigh Trading VolumeTCMDTactile Systems Technology3.0882 of 5 stars$13.49+1.5%$18.00+33.4%-8.6%$318.16M$292.98M19.27980Positive NewsGap DownZIMVZimVie2.3214 of 5 stars$11.49-1.5%$23.00+100.2%-39.1%$318.01M$449.75M-0.882,700Positive NewsSMTISanara MedTech1.9042 of 5 stars$35.69+6.2%$47.00+31.7%-14.6%$311.97M$78.06M-36.0560Gap DownLUNGPulmonx3.1997 of 5 stars$7.37-5.1%$13.36+81.2%-19.9%$293.30M$83.79M-5.12250RCELAVITA Medical1.6135 of 5 stars$9.32+4.0%$17.25+85.1%-48.7%$244.35M$64.25M-3.90130Short Interest ↑Positive NewsGap DownNVRONevro1.052 of 5 stars$5.79+0.3%$6.43+11.1%-54.1%$221.98M$408.52M-3.061,215News CoverageTrading HaltedELMDElectromed1.244 of 5 stars$24.45-1.1%$38.00+55.4%+56.3%$209.22M$59.63M32.60160News CoveragePositive NewsGap DownPROFProfound Medical2.0748 of 5 stars$6.81flat$14.25+109.3%-34.7%$204.57M$10.68M-5.08150 Remove Ads Related Companies and Tools Related Companies CVRx Competitors SANUWAVE Health Competitors Tactile Systems Technology Competitors ZimVie Competitors Sanara MedTech Competitors Pulmonx Competitors AVITA Medical Competitors Nevro Competitors Electromed Competitors Profound Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FONAR Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share FONAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.